Stock and Warrant Purchase Agreement November 02



Exhibit 10.16 
 
CALIFORNIA MICRO DEVICES CORPORATION 
 
STOCK AND WARRANT PURCHASE AGREEMENT 
 
November 22, 2002 
 







 
TABLE OF
CONTENTS 
 

	  	  	  	   	  Page


	  1.    Purchase and Sale of Stock and
Warrants
	   	  1

	                  1.1
	  	  Sale and Issuance of Common Stock
	   	  1

	                  1.2
	  	  Sale and Issuance of Warrants
	   	  1

	                  1.3
	  	  Closing
	   	  1

	
	  2.    Representations and Warranties of the
Company
	   	  1

	                  2.1
	  	  Corporate Existence and Power
	   	  2

	                  2.2
	  	  Authorization; No Contravention
	   	  2

	                  2.3
	  	  Governmental Authorization; Third Party Consents
	   	  2

	                  2.4
	  	  Binding Effect
	   	  2

	                  2.5
	  	  Litigation
	   	  3

	                  2.6
	  	  Compliance with Laws
	   	  3

	                  2.7
	  	  Capitalization
	   	  3

	                  2.8
	  	  No Default or Breach; Contractual Obligations
	   	  4

	                  2.9
	  	  Title to Properties
	   	  4

	                  2.10
	  	  Reports; Financial Statements
	   	  5

	                  2.11
	  	  Taxes
	   	  5

	                  2.12
	  	  No Material Adverse Change; Ordinary Course of Business
	   	  6

	                  2.13
	  	  Private Offering
	   	  6

	                  2.14
	  	  Labor Relations
	   	  6

	                  2.15
	  	  Employee Benefit Plans
	   	  7

	                  2.16
	  	  Liabilities
	   	  7

	                  2.17
	  	  Intellectual Property
	   	  8

	                  2.18
	  	  Potential Conflicts of Interest
	   	  9

	                  2.19
	  	  Trade Relations
	   	  9

	                  2.20
	  	  Outstanding Borrowing
	   	  10

	                  2.21
	  	  Broker’s, Finder’s or Similar Fees
	   	  10

	                  2.22
	  	  Disclosure
	   	  10

	                  2.23
	  	  Insurance
	   	  10

	                  2.24
	  	  Form S-3 Eligibility
	   	  10

	
	  3.    Representations and Warranties of the
Investors
	   	  10

	                  3.1
	  	  Authorization
	   	  10

	                  3.2
	  	  Purchase Entirely for Own Account
	   	  10

	                  3.3
	  	  Reliance Upon Investor’s Representations
	   	  11

	                  3.4
	  	  Receipt of Information
	   	  11

	                  3.5
	  	  Investment Experience
	   	  11

	                  3.6
	  	  Accredited Investor
	   	  11

	                  3.7
	  	  Restricted Securities
	   	  11

	                  3.8
	  	  Legends
	   	  11

	                  3.9
	  	  Broker’s, Finder’s or Similar Fees
	   	  12


 

-i- 









	  4.    Registration of the Shares; Compliance with
the Securities Act
	   	  12

	                  4.1
	  	  Registration Procedures and Expenses
	   	  12

	                  4.2
	  	  Transfer of Shares After Registration; Suspension
	   	  13

	                  4.3
	  	  Indemnification
	   	  15

	                  4.4
	  	  Termination of Conditions and Obligations
	   	  17

	
	  5.    Conditions of each Investor’s Obligations
at Closing
	   	  17

	                  5.1
	  	  Representations and Warranties
	   	  17

	                  5.2
	  	  Performance
	   	  17

	                  5.3
	  	  Compliance Certificate
	   	  17

	                  5.4
	  	  Qualifications
	   	  17

	                  5.5
	  	  Opinion of Counsel
	   	  18

	                  5.6
	  	  Minimum Amount Sold
	   	  18

	
	  6.    Conditions of the Company’s Obligations
at Closing
	   	  18

	                  6.1
	  	  Representations and Warranties
	   	  18

	                  6.2
	  	  Qualifications
	   	  18

	                  6.3
	  	  Minimum Amount Sold
	   	  18

	
	  7.    Miscellaneous
	   	  18

	                  7.1
	  	  Entire Agreement
	   	  18

	                  7.2
	  	  Survival
	   	  18

	                  7.3
	  	  Successors and Assigns
	   	  18

	                  7.4
	  	  Governing Law
	   	  19

	                  7.5
	  	  Counterparts
	   	  19

	                  7.6
	  	  Titles and Subtitles
	   	  19

	                  7.7
	  	  Notices
	   	  19

	                  7.8
	  	  Expenses
	   	  19

	                  7.9
	  	  Attorneys’ Fees
	   	  19

	                  7.10
	  	  Amendments and Waivers
	   	  19

	                  7.11
	  	  Severability
	   	  19

	                  7.12
	  	  Rights of the Investor
	   	  20

	                  7.13
	  	  Conflict of Interest Waiver
	   	  20

	                  7.14
	  	  Press Release/Form 8-K
	   	  20


 
Exhibits 
 
Exhibit A – Form of Warrant 
Exhibit B – Certificate of Subsequent Sale

Exhibit C – Form of Opinion of Company’s counsel 
Exhibit D – Schedule of Exceptions 
 

-ii- 








 
CALIFORNIA
MICRO DEVICES CORPORATION 
 
STOCK AND
WARRANT PURCHASE AGREEMENT 
 
This Stock and
Warrant Purchase Agreement (this “Agreement”) is made as of the 22nd day of November, 2002 (the “Effective Date”), by and among California Micro Devices Corporation, a California corporation (the “Company”), and each of
the persons listed on the signature pages hereto (each of whom is herein referred to individually as an “Investor” and collectively as the “Investors”). The parties hereto agree as follows: 
 
1. Purchase and Sale of Stock and Warrants.

 
1.1 Sale and Issuance of Common Stock.
Subject to the terms and conditions of this Agreement, each Investor severally (and not jointly and severally) agrees to purchase at the Closing (as defined below), and the Company agrees to issue and sell to each Investor at the Closing, that
number of shares (the “Shares”) of common stock, no par value, of the Company (the “Common Stock”) set forth above such Investor’s name on the signature pages hereto at a price per Share equal to $3.40 (the “Purchase
Price”), up to an aggregate of 2,800,000 shares of Common Stock. 
 
1.2 Sale and Issuance of Warrants. Subject to the terms and conditions of this Agreement, each Investor severally (and not jointly and severally) agrees to purchase at the Closing, and the Company agrees to issue and
sell to each Investor at the Closing, a warrant to purchase that number of shares of Common Stock (the “Warrant”), equal to twenty-five percent (25%) of the number of Shares purchased by such Investor, substantially in the form attached
hereto as Exhibit A. 
 
1.3 Closing.
The purchase and sale of the Shares and Warrants (the “Closing”) shall occur no later than November 29, 2002, at a place and time to be specified by the Company and Needham & Company, Inc. and Adams, Harkness & Hill, Inc.
(collectively, the “Placement Agents”), and of which the Investors will be notified in not less than one (1) business days in advance by the Placement Agents. At the Closing, after receipt of payment therefor, the Company shall arrange
delivery to each Investor of one or more stock certificates representing the number of Shares set forth above such Investor’s name on the signature pages hereto, and one or more Warrants, each to be registered in the name of the Investor. The
parties acknowledge that the schedule of Investors attached hereto as Schedule A is a preliminary schedule of investors. As soon as practicable after the Closing, the Company shall deliver to each Investor a completed Schedule A, listing each
Investor and the amount of Shares and Warrants purchased by such Investor hereunder. 
 
2. Representations and Warranties of the Company. The Company hereby represents and warrants to each Investor that, except as disclosed in all reports, registration statements and other filings,
together with any amendments thereto, filed by the Company with the Securities and Exchange Commission (the “SEC”) since June 25, 2002 (collectively, the “SEC Reports”), the Company’s press release dated October 24, 2002,
and the Schedule of Exceptions attached hereto as Exhibit D, specifically identifying the relevant subparagraph, which exceptions shall be deemed to be representations and warranties as if made hereunder: 
 

-1- 








 
2.1
Corporate Existence and Power. The Company, and each of the corporations or other entities of which the Company holds a majority of the voting power of the outstanding voting equity securities or a majority of the economic equity interest of
such corporation or entity (collectively, the “Subsidiaries”) (a) is a corporation duly organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation; (b) has all requisite corporate power and
authority to own and operate its property, to lease the property it operates as lessee and to conduct the business in which it is currently engaged; (c) is duly qualified as a foreign corporation, licensed and in good standing under the laws of each
jurisdiction in which its ownership, lease or operation of property or the conduct of its business requires such qualification, except where the failure to be so qualified could not reasonably be expected to have a material adverse effect on the
Condition of the Company and (d) has the corporate power and authority to execute, deliver and perform its obligations under this Agreement. 
 
2.2 Authorization; No Contravention. The execution, delivery and performance by the Company of this Agreement and the transactions
contemplated hereby and thereby (a) have been duly authorized by all necessary corporate action of the Company; (b) do not contravene the terms of the Articles of Incorporation or the By-laws; (c) do not violate, conflict with or result in any
breach, default or contravention of (or with due notice or lapse of time or both would result in any breach, default or contravention of), or the creation of any mortgage, deed of trust, pledge, hypothecation, assignment, encumbrance, lien
(statutory or otherwise) or preference, priority, right or other security interest or preferential arrangement (a “Lien”) under, any provision of any agreement, undertaking, contract, indenture, mortgage, deed of trust, or other instrument
to which the Company is a party or by which its property is bound (a “Contractual Obligation”) of the Company or any law, statute, treaty, rule, regulation, right, privilege, qualification, license or franchise (a “Requirement of
Law”) applicable to the Company except such violations or conflicts that would not reasonably be expected to have a material adverse effect on the Condition of the Company; and (d) do not violate any judgment, injunction, writ, award, decree or
order of any nature (collectively, “Orders”) of the government of any nation, state, city, locality or other political subdivision thereof, any entity exercising executive, legislative, judicial, regulatory or administrative functions of
or pertaining to government, (a “Governmental Authority”) against, or binding upon, the Company or any of its Subsidiaries. 
 
2.3 Governmental Authorization; Third Party Consents. No approval, consent, compliance, exemption, authorization or other action
by, or notice to, or filing with, any Governmental Authority or any other individual, firm, corporation, partnership, trust, association, joint venture, limited liability company, or other entity of any kind (a “Person”), and no lapse of a
waiting period under a Requirement of Law, is necessary or required in connection with the execution, delivery or performance (including, without limitation, the sale, issuance and delivery of the Shares and Warrants) by, or enforcement against, the
Company of this Agreement and the transactions contemplated hereby and thereby. 
 
2.4 Binding Effect. This Agreement has been duly executed and delivered by the Company, and this Agreement constitutes the legal, valid and binding obligations of the Company, enforceable
against the Company in accordance with their terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, fraudulent conveyance or transfer, moratorium or similar laws affecting the enforcement of
creditors’ rights 
 

-2- 








generally and by general principles of equity relating to enforceability (regardless of whether considered
in a proceeding at law or in equity). 
 
2.5
Litigation. There are no actions, suits, proceedings, claims, complaints, disputes, arbitrations or investigations (collectively, “Claims”) pending or, to the Knowledge of the Company’s executive officers (the
“Knowledge”) of the Company, threatened, at law, in equity, in arbitration or before any Governmental Authority against the Company or any of its Subsidiaries that seeks damages in an amount which is material to the Company’s
operations, other than ordinary routine litigation incidental to the business of the Company nor is the Company aware that there is any basis for any of the foregoing. The foregoing includes, without limitation, Claims pending or, to the Knowledge
of the Company, threatened or any basis therefor known by the Company involving the prior employment of any employee of the Company or any of its Subsidiaries, their use in connection with the business of the Company or any of its Subsidiaries of
any information or techniques allegedly proprietary to any of their former employers or their obligations under any agreements with prior employers. No Order has been issued by any court or other Governmental Authority against the Company or any of
its Subsidiaries purporting to enjoin or restrain the execution, delivery or performance of this Agreement or any of the other Transaction Documents. 
 
2.6 Compliance with Laws. The Company and each of its Subsidiaries is in compliance in all material respects with all Requirements
of Law and all Orders issued by any court or Governmental Authority against the Company in all respects. To the Company’s Knowledge, there are no Requirements of Law which could reasonably be expected to prohibit or restrict the Company or any
of its Subsidiaries from, or otherwise materially adversely effect the Company or any of its Subsidiaries in, conducting its business in any jurisdiction in which it now conducts its business. 
 
2.7 Capitalization. 
 
(a) The authorized capital stock of the Company consists of
25,000,000 shares of Common Stock, of which 14,249,270 shares (the “Issued Stock”) were issued and outstanding as of September 30, 2002, and 10,000,000 shares of preferred stock, of which 400,000 have been designated as “Series A
Participating Preferred Stock”, none of which was issued or outstanding as of September 30, 2002. As of September 30, 2002, 4,115,000 shares of Common Stock were reserved for issuance under the Company’s 1995 Employee Stock Option Plan, as
amended, 450,000 shares of Common Stock were reserved for issuance under the Company’s Non-Employee Directors’ Stock Option Plan, as amended, and 1,130,000 shares of Common Stock were reserved for issuance under the Company’s 1995
Employee Stock Purchase Plan. As of September 30, 2002, 1,736,610 shares of Common Stock had been issued and 2,061,541 shares of Common Stock were issuable upon the exercise of stock options granted under the Company’s 1995 Employee Stock
Option Plan, 105,255 shares of Common Stock had been issued and 251,064 shares of Common Stock were issuable upon the exercise of stock options granted under the Company’s 1995 Non-Employee Directors’ Stock Option Plan, and 853,175 shares
of Common Stock had been issued under the Company’s 1995 Employee Stock Purchase Plan. The Issued Stock represents all of the issued and outstanding shares of capital stock of the Company and all shares of Issued Stock have been duly authorized
and validly issued and are fully paid and nonassessable. All of the shares of Issued Stock and other securities of the Company have 
 

-3- 








been offered, issued and sold by the Company in compliance in all material respects with the Securities
Act of 1933, as amended (“the Securities Act”) and applicable state securities laws. There are no contracts or other agreements relating to the issuance, sale or transfer of Issued Stock or any equity or other securities of the Company
other than pursuant to the 1995 Employee Stock Option Plan, as amended; the 1995 Non-Employee Directors’ Stock Option Plan, as amended; the 1995 Employee Stock Purchase Plan, as amended; an unsigned Investment Letter proposed to Jeff Kalb
relating to a 10,000 share bonus offered to him and included as Issued Stock; a warrant for 59,750 shares of Common Stock held by Needham & Company, Inc.; the warrants issuable to the Placement Agents in connection with this Agreement; and the
Shares and Warrants issuable pursuant to this Agreement. 
 
(b) The Shares and Warrants are duly authorized, and the Shares and shares of Common Stock issuable upon exercise of the Warrants (the “Warrant Shares”)when issued and delivered to the Purchasers after payment therefor,
will be validly issued, fully paid and non-assessable, and assuming the accuracy of the representations and warranties of the Purchasers set forth in Section 3 of this Agreement, will be issued in compliance with the registration and qualification
requirements of all applicable federal, state and foreign securities laws and will be free and clear of all other Liens. None of the issued and outstanding shares of Common Stock were issued in violation of any preemptive rights. 
 
2.8 No Default or Breach; Contractual Obligations. All
of the Contractual Obligations to which the Company or any of its Subsidiaries is a party, whether written or oral, which are required by the Exchange Act to be disclosed in the SEC Reports (collectively, “Material Contractual
Obligations”) are valid, subsisting, in full force and effect and binding upon the Company or its Subsidiary, as the case may be, and, to the Knowledge of the Company, the other parties thereto, and the Company or its Subsidiary, as the case
may be, has paid in full or accrued all amounts due thereunder and has satisfied in full or provided for all of its liabilities and obligations thereunder, except for such amounts as are being contested by the Company in good faith. Neither the
Company nor any of its Subsidiaries has received notice of a default and is not in default under, or with respect to, any Material Contractual Obligation nor, to the Knowledge of the Company, does any condition exist that with notice or lapse of
time or both would constitute a default thereunder. To the Knowledge of the Company, no other party to any such Contractual Obligation is in default thereunder, nor does any condition exist that with notice or lapse of time or both would constitute
a default by such other party thereunder. 
 
2.9
Title to Properties. The Company and each of its Subsidiaries has good, record and marketable title in fee simple to, or holds interests as lessee under leases in full force and effect in, all real property used in connection with its
business or otherwise owned or leased by it, in each case free and clear of all Liens, except for Liens that would required to be described in the notes to the Financial Statements. The Company and each of its Subsidiaries owns and has good, valid
and marketable title to all of its properties and assets used in its business or reflected as owned on the Financial Statements, in each case free and clear of all Liens, except for Liens that would required to be described in the notes to the
Financial Statements. 
 

-4- 








 
2.10
Reports; Financial Statements. 
 
(a) As of
the respective dates of their filing with the Commission, the SEC Reports, complied in all material respects with the applicable requirements of the Securities Act, the Exchange Act, and the rules and regulations of the Commission promulgated
thereunder, except as disclosed in the SEC Reports. Except as disclosed in the SEC Reports, the SEC Reports did not at the time they were filed with the Commission, or will not at the time they are filed with the Commission, contain any untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they are made, not misleading. The Company is not aware
of any issues raised by the Commission with respect to any of the SEC Reports, other than those disclosed in the SEC Reports. 
 
(b) Except as disclosed in the SEC Reports, the consolidated financial statements (including, in each case, any related schedules or notes
thereto) contained in or incorporated by reference in the SEC Reports and any such reports, registration statements and other filings to be filed by the Company with the Commission prior to the Closing Date (the “Financial Statements”) (i)
have been or will be prepared in accordance with the published rules and regulations of the Commission and GAAP consistently applied during the periods involved (except as may be indicated in the notes thereto) and (ii) fairly present or will fairly
present in all material respects the consolidated financial position of the Company and its Subsidiaries as of the respective dates thereof and the consolidated results of operations, statements of stockholders’ equity and cash flows for the
periods indicated, except that any unaudited interim financial statements were or will be subject to normal and recurring year-end adjustments and may omit footnote disclosure as permitted by regulations of the Commission. 
 
2.11 Taxes. 
 
(a) The Company and each of its Subsidiaries has paid all
federal, state, provincial, county, local, foreign and other taxes (the “Taxes”) which have come due and are required to be paid by it through the date hereof, and all deficiencies or other additions to Tax, interest and penalties owed by
it in connection with any such Taxes, other than Taxes being disputed by the Company in good faith for which adequate reserves have been made in accordance with GAAP; 
 
(b) The Company and each of its Subsidiaries has timely filed or caused to be filed all returns for Taxes
that it is required to file on and through the date hereof (including all applicable extensions), and all such Tax returns are accurate and complete in all material respects; 
 
(c) With respect to all Tax returns of the Company and each of its Subsidiaries, (i) there is no unassessed
Tax deficiency proposed or, to the Knowledge of the Company, threatened against the Company or any of its Subsidiaries and (ii) no audit is in progress with respect to any return for Taxes, no extension of time is in force with respect to any date
on which any return for Taxes was or is to be filed and no waiver or agreement is in force for the extension of time for the assessment or payment of any Tax; 
 
(d) All provisions for Tax liabilities of the Company and each of its Subsidiaries have been disclosed in the Financial Statements and
made in accordance with GAAP consistently 
 

-5- 








applied, and all liabilities for Taxes of the Company and each of its Subsidiaries attributable to periods
prior to or ending on the Closing Date have been adequately disclosed in the Financial Statements; and 
 
(e) There are no Liens for Taxes on the assets of the Company or any of its Subsidiaries. 
 
2.12 No Material Adverse Change; Ordinary Course of
Business. Since September 30, 2002, except as disclosed in or incorporated by reference in the SEC Reports, (a) there has not been any material adverse change, in the Condition of the Company, (b) neither the Company nor any of its Subsidiaries
has participated in any transaction material to the Condition of the Company, including, without limitation, declaring or paying any dividend or declaring or making any distribution to its stockholders except out of the earnings of the Company or
its Subsidiary, as the case may be, (c) neither the Company nor any of its subsidiaries has entered into any Material Contractual Obligation, other than in the ordinary course of business, (d) there has not occurred a material change in the
accounting principles or practice of the Company or any of its Subsidiaries except as required by reason of a change in GAAP, and (e) there has not been any issuance of Company capital stock, or warrants, options or other rights to purchase Company
capital stock, except for (a) options granted and shares issued under the Company stock option and purchase plans, (2) warrants promised to the Placement Agents in connection with the offering of the Shares and Warrants, and (3) the Shares and
Warrants. 
 
2.13 Private Offering. Neither
the Company nor any authorized Person acting on its behalf has, in connection with the offer, sale, exchange or issuance of the Shares or Warrants, engaged in (i) any form of general solicitation or general advertising (as those terms are used
within the meaning of Rule 502(c) under the Securities Act), (ii) any action involving a public offering within the meaning of Section 4(2) of the Securities Act, or (iii) any action that would require the registration under the Securities Act of
the offering, sale, exchange or issuance of the Shares or Warrants pursuant to this Agreement or that would violate applicable state securities or “blue sky” laws. The Company has not made and will not prior to the Closing Date make,
directly or indirectly, any offer or sale of the Shares, Warrants, or of securities of the same or similar class as the Shares or Warrants, if, as a result, the offer and sale contemplated hereby would fail to be entitled to exemption from the
registration requirements of the Securities Act. As used herein, the terms “offer” and “sale” have the meanings specified in Section 2(3) of the Securities Act. 
 
2.14 Labor Relations. Except as could not reasonably be expected to have a material adverse effect on
the Condition of the Company: (a) neither the Company nor any of its Subsidiaries is engaged in any unfair labor practice; (b) there is no strike, labor dispute, slowdown or stoppage pending or, to the Knowledge of the Company, threatened against
the Company or any of its Subsidiaries ; (c) neither the Company nor any of its Subsidiaries is a party to any collective bargaining agreement or contract; and (d) no union organizing activities are taking place. To the Knowledge of the Company,
each of the officers and key employees of the Company and each of its Subsidiaries spends all, or substantially all, of his business time on the business of the Company or its Subsidiary, as the case may be. To the Knowledge of the Company, none of
the employees of the Company or any of its Subsidiaries is resident in the United States in violation of any Requirement of Law. 
 

-6- 








 
2.15
Employee Benefit Plans. 
 
(a) The SEC
Reports list or describe each Plan that the Company or any of its Subsidiaries maintains or to which the Company or any of its Subsidiaries contributes (the “Company Plans”). Neither the Company nor any of its Subsidiaries has any
liability under any Plans other than the Company Plans. Except as described in or incorporated by reference in the SEC Reports, neither the Company nor any Commonly Controlled Entity maintains or contributes to, or has within the preceding six years
maintained or contributed to, or may have any liability with respect to any Plan subject to Title IV of ERISA or Section 412 of the Code or any “multiple employer plan” within the meaning of the Code or ERISA. Each Company Plan (and
related trust, insurance contract or fund) has been established and administered in accordance with its terms, and complies in form and in operation with the applicable requirements of ERISA and the Code and other applicable Requirements of Law. All
contributions (including all employer contributions and employee salary reduction contributions) which are due have been paid to each Company Plan. 
 
(b) No Claim with respect to the administration or the investment of the assets of any Company Plan (other than routine claims for
benefits) is pending. 
 
(c) Except as could not
reasonably be expected to have a material adverse effect on the Condition of the Company, each Company Plan that is intended to be qualified under Section 401(a) of the Code is so qualified and has been so qualified during the period since its
adoption; each trust created under any such Plan is exempt from tax under Section 501(a) of the Code and has been so exempt since its creation. 
 
(d) No Company Plan is a welfare plan (as defined in Section (3)(l) of ERISA) that provides benefits to current or former employees beyond
their retirement or other termination of service (other than coverage mandated by Section 4980A of the Code, commonly referred to as “COBRA”, the cost of which is fully paid by the current or former employee or his or her dependents).

 
(e) Neither the consummation of the transactions
contemplated by this Agreement nor any termination of employment following such transactions will accelerate the time of the payment or vesting of, or increase the amount of, compensation due to any employee or former employee whether or not such
payment would constitute an “excess parachute payment” under Section 280G of the Code. 
 
(f) There are no unfunded obligations under any Company Plan which are not fully reflected in the Financial Statements. 
 
(g) Except as could not reasonably be expected to have a material adverse effect on the Condition of the
Company, the Company has no liability, whether absolute or contingent, including any obligations under any Company Plan, with respect to any misclassification of any person as an independent contractor rather than as an employee. 
 
2.16 Liabilities. Neither the Company nor any of its
Subsidiaries has any direct or indirect obligation or liability (the “Liabilities”) which are not fully reflected or reserved against in the Financial Statements, other than Liabilities not exceeding $250,000 in the aggregate 
 

-7- 








incurred since September 30, 2002 in the ordinary course of business. The Company has no Knowledge of any
circumstance, condition, event or arrangement that could reasonably be expected to give rise hereafter to any Liabilities of the Company or any of its Subsidiaries that, individually or in the aggregate, could have a material adverse effect on the
Condition of the Company. 
 
2.17 Intellectual
Property. 
 
(a) (i) The Company and each of
its Subsidiaries is the owner of all, or has the license or right to use all, of the copyrights, patents, trade secrets, trademarks, internet assets, software and other proprietary rights (collectively, “Intellectual Property”) that are
used in connection with its business as presently conducted, free and clear of all Liens except for a limited security interest of and a negative pledge agreement with Silicon Valley Bank. 
 
(ii) None of the Intellectual Property is subject to any outstanding Order, and no action,
suit, proceeding, hearing, investigation, charge, complaint, claim or demand is pending or, to the Knowledge of the Company, threatened, which challenges the validity, enforceability, use or ownership of the item. 
 
(iii) The Company and each of its Subsidiaries
has substantially performed all obligations imposed upon it under all Intellectual Property licenses, sublicenses, distributor agreements and other agreements under which the Company or any of its Subsidiaries is either a licensor, licensee or
distributor, except such licenses, sublicenses and other agreements relating to off-the-shelf software which is commercially available on a retail basis and used solely on the computers of the Company or its Subsidiaries (collectively, the “IP
Agreements”). The Company and each of its Subsidiaries is not, nor to the Knowledge of the Company is any other party thereto, in breach of or default thereunder in any respect, nor is there any event which with notice or lapse of time or both
would constitute a default thereunder. All of the IP Agreements are valid, enforceable and in full force and effect, and will continue to be so on identical terms immediately following the Closing except as enforceability may be limited by
applicable bankruptcy, insolvency, reorganization, fraudulent conveyance or transfer, moratorium or similar laws affecting the enforcement of creditors’ rights generally and by general principles of equity relating to enforceability (regardless
of whether considered in a proceeding at law or in equity). 
 
(iv) To the Knowledge of the Company, none of the Intellectual Property currently sold or licensed by the Company or any of its Subsidiaries to any Person or used by or licensed to the Company or any
of its Subsidiaries by any Person infringes upon or otherwise violates any Intellectual Property rights of others, except as could not reasonably be expected to have a material adverse effect on the Condition of the Company. 
 
(b) No litigation is pending and no Claim has been made
against the Company or any of its Subsidiaries or, to the Knowledge of the Company, is threatened, contesting the right of the Company or any of its Subsidiaries to sell or license to any Person or use the Intellectual 
 

-8- 








Property presently sold or licensed to such Person or used by the Company or any of its Subsidiaries. To
the Knowledge of the Company, no Person is infringing upon or otherwise violating the Intellectual Property rights of the Company or any of its Subsidiaries. 
 
(c) No former employer of any employee of the Company or any of its Subsidiaries has made a claim against the Company or any of its
Subsidiaries or, to the Knowledge of the Company, against any other Person, that such employee or such consultant is utilizing Intellectual Property of such former employer. 
 
(d) To the Knowledge of the Company, none of the trade secrets, wherever located, the value of which is
contingent upon maintenance of confidentiality thereof, has been disclosed to any Person other than employees, representatives and agents of the Company or any of its Subsidiaries, except as required pursuant to the filing of a patent application by
the Company or any of its Subsidiaries. 
 
(e) It
is not necessary for the business of the Company or any of its Subsidiaries to use any Intellectual Property owned by any director, officer, employee or consultant of the Company or any of its Subsidiaries (or persons the Company or any of its
Subsidiaries presently intends to hire). To the Company’s Knowledge, at no time during the conception or reduction to practice of any of the Intellectual Property of the Company or any of its Subsidiaries was any developer, inventor or other
contributor to such Intellectual Property operating under any grants from any Governmental Authority or subject to any employment agreement, invention assignment, nondisclosure agreement or other Contractual Obligation with any Person that could
materially adversely affect the rights of the Company or any of its Subsidiaries to its Intellectual Property. 
 
2.18 Potential Conflicts of Interest. To the Knowledge of the Company based upon the officers and directors questionnaires
distributed and completed in connection with the Company’s 2002 Proxy Statement, no officer, director or stockholder beneficially owning more than 5% of the outstanding shares of Common Stock of the Company, no spouse of any such officer,
director or stockholder, and no affiliate (as defined in Rule 12b-2 of the Exchange Act) of any of the foregoing (a) owns, directly or indirectly, any interest in (excepting less than one percent (1%) stock holdings for investment purposes in
securities of publicly held and traded companies), or is an officer, director, employee or consultant of, any Person which is, or is engaged in business as, a competitor, lessor, lessee, supplier, distributor, or customer of, or lender to or
borrower from, the Company or any of its Subsidiaries; (b) owns, directly or indirectly, in whole or in part, any tangible or intangible property that the Company or any of its Subsidiaries use, in the conduct of business; or (c) has any cause of
action or other claim whatsoever against, or owes or has advanced any amount to, the Company, except for claims in the ordinary course of business such as for accrued vacation pay, accrued benefits under employee benefit plans, and similar matters
and agreements existing on the date hereof. 
 
2.19
Trade Relations. There exists no actual or, to the Knowledge of the Company, threatened termination, cancellation or limitation of, or any material adverse modification or change in, the business relationship of the Company or any of its
subsidiaries, or the business of the Company or any of its subsidiaries, with any customer or supplier or any group of customers 
 

-9- 








or suppliers whose purchases or inventories provided to the business of the Company or any of its
subsidiaries are individually or in the aggregate material to the Condition of the Company. 
 
2.20 Outstanding Borrowing. The SEC Reports set forth the amount of all indebtedness of the Company and each of its Subsidiaries as of September 30, 2002, which, except for accounts payable
incurred in the ordinary course of business has not changed materially through the Effective Date. No indebtedness is entitled to any voting rights in any matters voted upon by the holders of the Common Stock. 
 
2.21 Broker’s, Finder’s or Similar Fees.
Except for fees payable to the Placement Agents, there are no brokerage commissions, finder’s fees or similar fees or commissions payable by the Company or any of its Subsidiaries in connection with the transactions contemplated hereby based on
any agreement, arrangement or understanding with the Company or any of its Subsidiaries or any action taken by any such Person. 
 
2.22 Disclosure. This Agreement, the Private Placement Memorandum dated October 14, 2002 (the “PPM”), the SEC Reports,
and the documents and certificates furnished to the Purchasers by the Company do not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements contained herein or therein, in the light
of the circumstances under which they were made, not misleading. 
 
2.23 Insurance. The Company maintains insurance of the types, against such losses and in amounts and with such insurers as are customary in the Company’s industry and otherwise reasonably prudent, including, but not
limited to, insurance covering all real property owned and leased by the Company against theft, damage, destruction, and other risks customarily insured by similarly situated companies. 
 
2.24 Form S-3 Eligibility. As of the date hereof, the Company meets the requirements for the use of
Form S-3 for registration of resale of the Shares and Warrant Shares as contemplated herein. 
 
3. Representations and Warranties of the Investors. Each Investor hereby represents and warrants to the Company that, solely as to such Investor: 
 
3.1 Authorization. The Investor has all requisite
corporate power and authority to enter into this Agreement and that this Agreement constitutes a valid and legally binding obligation of the Investor, except (a) as limited by applicable bankruptcy, insolvency, reorganization, moratorium and other
laws of general application affecting the enforcement of creditors’ rights generally, (b) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies, and (c) to the extent the
indemnification provisions contained in this Agreement may be limited by applicable federal or state securities laws. 
 
3.2 Purchase Entirely for Own Account. The Shares and Warrants to be purchased by the Investor, and the Warrant Shares which the
Investor may purchase upon exercise of the Warrant (collectively the “Securities”), will be acquired for investment for the Investor’s own account, and not as a nominee or agent, and not with a view to the resale or distribution of
any part thereof, and the Investor has no present intention of selling, granting any participation in, or 
 

-10- 








otherwise distributing the same. The Investor is not a party to any contract, undertaking, agreement or
arrangement with any person to sell, transfer or otherwise dispose of any of the Securities. 
 
3.3 Reliance Upon Investor’s Representations. The Investor understands that the issuance and sale of the Securities to it will not be registered under the Securities Act on the ground that
such issuance and sale will be exempt from registration under the Securities Act pursuant to section 4(2) thereof, and that the Company’s reliance on such exemption is based on each Investor’s representations set forth herein. The Investor
realizes that the basis for the exemption may not be present if, notwithstanding such representations, any Investor has in mind merely acquiring the Securities for a fixed or determinable period in the future, or for a market rise, or for sale if
the market does not rise. Such Investor has no such present intention. 
 
3.4 Receipt of Information. The Investor has received the PPM and has had an opportunity to ask questions and receive answers from the Company regarding the PPM and the terms and conditions of the issuance and sale of
the Shares and Warrant and the business, properties, prospects and financial condition of the Company and to obtain additional information (to the extent the Company possessed such information or could acquire it without unreasonable effort or
expense) necessary to verify the accuracy of any information furnished to it or to which it had access. The foregoing, however, does not limit or modify the representations and warranties of the Company in Section 2 of this Agreement or the right of
the Investor to rely thereon. No person other than the Company has been authorized to give any information other than the PPM or to give any representation not contained in this Agreement in connection with the Offering and, if given or made, such
information or representation must not be relied upon as having been authorized by the Company. 
 
3.5 Investment Experience. The Investor is experienced in evaluating and investing in securities of companies and acknowledges that it is able to fend for itself, can bear the economic risk of
its investment, and has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of the investment in the Securities. 
 
3.6 Accredited Investor. The Investor is an “accredited investor” as such term is defined in
Rule 501 of Regulation D promulgated under the Securities Act, for the reason indicated on the signature page of this Agreement. 
 
3.7 Restricted Securities. The Investor understands that the Securities may not be sold, transferred or otherwise disposed of
without registration under the Securities Act or an exemption therefrom, and that in the absence of an effective registration statement covering the Securities or an available exemption from registration under the Securities Act, the Securities must
be held indefinitely. In particular, the Investor is aware that the Securities may not be sold pursuant to Rule 144 promulgated under the Securities Act unless all of the conditions of that Rule are met. Among the conditions for use of Rule 144 is
the availability of current information to the public about the Company. 
 
3.8 Legends. To the extent applicable, each certificate or other document evidencing any of the Securities shall be endorsed with the legends set forth below, and the Investor 
 

-11- 








covenants that, except to the extent such restrictions are waived by the Company, the Investor shall not
transfer the shares represented by any such certificate without complying with the restrictions on transfer described in the legends endorsed on such certificate: 
 
(a) The following legend under the Act: 
 
“THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED OR QUALIFIED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE SOLD, OFFERED FOR SALE, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED IN THE ABSENCE OF A REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO THE
SECURITIES UNDER SUCH ACT OR ELSE UPON AN OPINION OF COUNSEL OR OTHER EVIDENCE REASONABLY SATISFACTORY TO CALIFORNIA MICRO DEVICES CORPORATION THAT SUCH REGISTRATION IS NOT REQUIRED OR UNLESS SOLD PURSUANT TO RULE 144 OF SUCH ACT OR ANOTHER
APPLICABLE EXEMPTION.” 
 
(b) Such other
legends as may be required under state securities laws. 
 
3.9 Broker’s, Finder’s or Similar Fees. There are no brokerage commissions, finder’s fees or similar fees or commissions payable by the Investor in connection with the transactions contemplated hereby based on
any agreement, arrangement or understanding with the Investor or any action taken by any such Person. 
 
4. Registration of the Shares; Compliance with the Securities Act. 
 
4.1 Registration Procedures and Expenses. The Company hereby agrees that it shall: 
 
(a) subject to receipt of necessary information from the
Investors, prepare and file with the SEC on or before the date one month after the Closing Date a registration statement on Form S-3 (the “Registration Statement”) to enable the resale of the Shares and the Warrant Shares by the Investors
and use reasonable best efforts to respond to comments from the SEC promptly and cause such Registration Statement to be declared effective as promptly as practicable after filing and to remain continuously effective until the earlier of (i) the
second anniversary of the Closing, or (ii) such time as all Shares purchased by the Investors pursuant to this Agreement have been sold thereunder (the “Registration Period”). For each full calendar month after the Closing that the
Registration Statement is not be declared effective by the SEC starting with three (3) months after the Closing and ending with twenty-four (24) months after the Closing, each Investor shall be issued two percent of the number of Shares originally
issued to the Investor (the “Penalty Shares”) within fifteen days. Thus, for example, if an Investor purchased 100,000 Shares, and the Registration Statement was not declared effective until four months and five days after the Closing,
then on or before each of the dates (a) four months and fifteen days after the Closing and (b) five months and fifteen days after the Closing, such Investor would be issued 2,000 Penalty Shares. All such Penalty Shares shall be considered as Shares
for purposes of this Agreement, except Section 1. 
 

-12- 








 
(b) prepare
and file with the SEC such amendments and supplements to the Registration Statement and the prospectus used in connection therewith as may be necessary to keep the Registration Statement effective until the end of the Registration Period;

 
(c) notify Investors promptly upon the
effectiveness of the Registration Statement and furnish to the Investors with respect to the shares of Common Stock registered under the Registration Statement such reasonable number of copies of the Registration Statement, prospectuses and
preliminary prospectuses in conformity with the requirements of the Securities Act and such other documents as the Investor may reasonably request, in order to facilitate the public sale or other disposition of all or any of the Shares or Warrant
Shares by the Investor; 
 
(d) file documents
required of the Company for normal blue sky clearance in states specified in writing by the Investor, provided, however, that the Company shall not be required to qualify to do business or consent to service of process in any jurisdiction in which
it is not now so qualified or has not so consented; 
 
(e) use its reasonable best efforts to cause the Shares and Warrant Shares to be listed on Nasdaq in connection with the filing of the Registration Statement under Section 4.1(a); 
 
(f) bear all expenses in connection with the procedures in
paragraph (a) through (e) of this Section 4.1 and the registration of the Shares and the Warrant Shares pursuant to the Registration Statement other than fees and expenses, if any, of counsel or other advisers to the Investors or underwriting
discounts, brokerage fees and commissions incurred by the Investors, if any. 
 
(g) provide that all Shares and Warrant Shares covered by the Registration Statement will be listed on the Nasdaq National Market or other securities market on which the Company’s Common Stock is
then listed or traded. 
 
It shall be a condition
precedent to the obligations of the Company to take any action pursuant to this Section 4.1 that the Investor shall furnish to the Company such information regarding itself, the shares of Common Stock to be sold by the Investor, and the intended
method of disposition of such securities as shall be required to effect the registration of the Shares and the Warrant Shares. 
 
4.2 Transfer of Shares After Registration; Suspension. 
 
(a) Subject to Section 4.4, the Investors agree that they will not offer to sell, solicit offers to buy,
dispose of, loan, pledge or grant any right (each, a “Disposition”) with respect to the Securities that would constitute a sale within the meaning of the Securities Act except pursuant to the Registration Statement referred to in Section
4.1, and that they will promptly notify the Company of any changes in the information set forth in the Registration Statement after it is prepared regarding the Investor or its plan of distribution. 
 
(b) In addition to any suspension rights under paragraph (c)
below, the Company may, upon the happening of any event, that, in the good faith judgment of Company’s board of directors upon the opinion of counsel, renders it advisable to suspend use of the prospectus for 
 

-13- 








no more than sixty (60) days in the aggregate in any twelve (12) month period of time due to pending
corporate developments, public filings with the SEC or similar events, suspend use of the prospectus on written notice to each Investor, in which case each Investor shall discontinue disposition of Shares or the Warrant Shares covered by the
Registration Statement or prospectus until copies of a supplemented or amended prospectus are distributed to the Investors or until the Investors are advised in writing by the Company that the use of the applicable prospectus may be resumed.

 
(c) Subject to paragraph (d) below, in the event
of: (i) any request by the SEC or any other federal or state governmental authority during the period of effectiveness of the Registration Statement for amendments or supplements to a Registration Statement or related prospectus or for additional
information, (ii) the issuance by the SEC or any other federal or state governmental authority of any stop order suspending the effectiveness of a Registration Statement or the initiation of any proceedings for that purpose, (iii) the receipt by the
Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Shares or the Warrant Shares for sale in any jurisdiction or the initiation of any proceeding for such purpose, (iv) any
event or circumstance which necessitates the making of any changes in the Registration Statement or prospectus, or any document incorporated or deemed to be incorporated therein by reference, so that, in the case of the Registration Statement, it
will not contain any untrue statement of a material fact or any omission to state a material fact required to be stated therein or necessary to make the statements therein not misleading, and that in the case of the prospectus, it will not contain
any untrue statement of a material fact or any omission to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, then the
Company shall deliver a certificate in writing to the Investors (the “Suspension Notice”) to the effect of the foregoing and, upon receipt of such Suspension Notice, the Investors will refrain from selling any Shares or Warrant Shares
pursuant to the Registration Statement (a “Suspension”) until the Investors’ receipt of copies of a supplemented or amended prospectus prepared and filed by the Company, or until it is advised in writing by the Company that the
current prospectus may be used, and has received copies of any additional or supplemental filings that are incorporated or deemed incorporated by reference in any such prospectus. In the event of any Suspension, the Company will use its reasonable
best efforts to cause the use of the prospectus so suspended to be resumed as soon as possible within twenty (20) business days after delivery of a Suspension Notice to the Investors. In addition to and without limiting any other remedies (including
without limitation at law or equity), available to the Investors, the Investors shall be entitled to specific performance in the event the Company fails to comply with the provisions of this Section 4.2(c). 
 
(d) Provided that a Suspension is not then in effect, the
Investors may sell Shares or Warrant Shares under the Registration Statement, provided that the selling Investor arranges for delivery of a current prospectus to the transferee of such Shares or Warrant Shares. 
 
(e) In the event of a sale of Shares or Warrant Shares by an
Investor, such Investor must also deliver to the Company’s transfer agent, with a copy to the Company, a Certificate of Subsequent Sale substantially in the form attached hereto as Exhibit B, so that ownership of the Shares or Warrant
Shares may be properly transferred. 
 

-14- 








 
(f) For so
long as the Company will have a class of securities registered under Section 12(b) or Section 12(g) of the Exchange Act, the Company covenants that it will file, on a timely basis, any reports required to be filed by it under the Exchange Act and
the rules and regulations adopted by the SEC thereunder and keep all such reports and public information current to the extent required by Rule 144 under the Securities Act for a period of two (2) years after the Closing. 
 
4.3 Indemnification. For the purpose of this Section
4.3 only, (i) the term “Registration Statement” shall include any final prospectus, exhibit, supplement or amendment included in or relating to the Registration Statement referred to in Section 4.1(a); and (ii) the term “untrue
statement” shall include any untrue statement or any omission to state in the Registration Statement a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they
were made, not misleading. 
 
(a) The Company
agrees to indemnify and hold harmless each Investor (and each person, if any, who controls such Investor within the meaning of section 15 of the Securities Act) from and against any losses, claims, damages or liabilities to which such Investor (or
such person, if any, who controls such Investor within the meaning of section 15 of the Securities Act) may become subject (under the Securities Act or otherwise) insofar as such losses, claims, damages or liabilities (or actions or proceedings in
respect thereof) arise out of, or are based upon (i) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, or (ii) any failure by the Company to fulfill any undertaking included in the
Registration Statement, and the Company will reimburse such Investor (and each person, if any, who controls such Investor within the meaning of section 15 of the Securities Act) for any reasonable legal or other expenses reasonably incurred in
investigating, defending or preparing to defend any such action, proceeding or claim; provided, however, that the Company shall not be liable in any such case to the extent that such loss, claim, damage or liability arises out of, or is based upon,
an untrue statement made in such Registration Statement in reliance upon and in conformity with written information furnished to the Company by or on behalf of such Investor specifically for use in preparation of the Registration Statement or the
failure of such Investor to comply with its covenants and agreements contained in Section 3 or 4.2 hereof or any statement or omission in any prospectus that is corrected in any subsequent prospectus that was delivered to the Investor prior to the
pertinent sale or sales by the Investor. 
 
(b)
Each Investor agrees to indemnify and hold harmless the Company (and each person, if any, who controls the Company within the meaning of section 15 of the Securities Act, each officer of the Company who signs the Registration Statement and each
director of the Company) and each other Investor from and against any losses, claims, damages or liabilities to which the Company (or any such officer, director or controlling person) or other Investor may become subject (under the Securities Act or
otherwise), insofar as such losses, claims, damages or liabilities (or actions or proceedings in respect thereof) arise out of, or are based upon a breach of its covenants and agreements contained in Section 3 or 4.2 hereof or any statement or
omission in any prospectus that is corrected in any subsequent prospectus that was delivered to the Investor prior to the pertinent sale or sales by the Investor or any untrue statement or alleged untrue statement of a material fact contained in the
Registration Statement if such untrue statement was made in reliance upon and in conformity with information furnished by or on 
 

-15- 








behalf of the indemnifying Investor in writing specifically for use in preparation of the Registration
Statement, and the indemnifying Investor will reimburse the Company (or such officer, director or controlling person) or other Investor, as the case may be, for any legal or other expenses reasonably incurred in investigating, defending or preparing
to defend any such action, proceeding or claim; providing further that, the Investor’s obligations to indemnify under this subsection (b) shall be limited to the amount received by the Investor from the sale of the Investor’s Shares
hereunder. 
 
(c) Promptly after receipt by any
indemnified person of a notice of a claim or the beginning of any action in respect of which indemnity is to be sought against an indemnifying person pursuant to this Section 4.3, such indemnified person shall notify the indemnifying person in
writing of such claim or of the commencement of such action, but the omission to so notify the indemnifying party will not relieve it from any liability which it may have to any indemnified party under this Section 4.3 (except to the extent that
such omission materially and adversely affects the indemnifying party’s ability to defend such action) or from any liability otherwise than under this Section 4.3. Subject to the provisions hereinafter stated, in case any such action shall be
brought against an indemnified person, the indemnifying person shall be entitled to participate therein, and, to the extent that it shall elect by written notice delivered to the indemnified party promptly after receiving the aforesaid notice from
such indemnified party, shall be entitled to assume the defense thereof, with counsel reasonably satisfactory to such indemnified person. After notice from the indemnifying person to such indemnified person of its election to assume the defense
thereof, such indemnifying person shall not be liable to such indemnified person for any legal expenses subsequently incurred by such indemnified person in connection with the defense thereof. In no event shall any indemnifying person be liable in
respect of any amounts paid in settlement of any action unless the indemnifying person shall have approved the terms of such settlement; provided that such consent shall not be unreasonably withheld. No indemnifying person shall, without the prior
written consent of the indemnified person, effect any settlement of any pending or threatened proceeding in respect of which any indemnified person is or could have been a party and indemnification could have been sought hereunder by such
indemnified person, unless such settlement includes an unconditional release of such indemnified person from all liability on claims that are the subject matter of such proceeding. 
 
(d) If the indemnification provided for in this Section 4.3 is unavailable to or insufficient to hold
harmless an indemnified party under subsection (a) or (b) above in respect of any losses, claims, damages or liabilities (or actions or proceedings in respect thereof) referred to therein, then each indemnifying party shall contribute to the amount
paid or payable by such indemnified party as a result of such losses, claims, damages or liabilities (or actions in respect thereof) in such proportion as is appropriate to reflect the relative fault of the Company on the one hand and the Investors
on the other in connection with the statements or omissions or other matters which resulted in such losses, claims, damages or liabilities (or actions in respect thereof), as well as any other relevant equitable considerations. The relative fault
shall be determined by reference to, among other things, in the case of an untrue statement, whether the untrue statement relates to information supplied by the Company on the one hand or an Investor on the other and the parties’ relative
intent, knowledge, access to information and opportunity to correct or prevent such untrue statement. The Company and the Investors agree that it would not be just and equitable if contribution pursuant to this subsection (d) were determined by pro
rata 
 

-16- 








allocation (even if the Investors were treated as one entity for such purpose) or by any other method of
allocation which does not take into account the equitable considerations referred to above in this subsection (d). The amount paid or payable by an indemnified party as a result of the losses, claims, damages or liabilities (or actions in respect
thereof) referred to above in this subsection (d) shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the
provisions of this subsection (d), no Investor shall be required to contribute any amount in excess of the amount by which the gross amount received by the Investor from the sale of the Shares to which such loss relates exceeds the amount of any
damages which such Investor has otherwise been required to pay by reason of such untrue statement. No person guilty of fraudulent misrepresentation (within the meaning of section 11(f) of the Securities Act) shall be entitled to contribution from
any person who was not guilty of such fraudulent misrepresentation. The Investors’ obligations in this subsection to contribute are several in proportion to their sales of Shares to which such loss relates and not joint. 
 
4.4 Termination of Conditions and Obligations. The
conditions precedent imposed by Section 4 upon the transferability of the Shares and the shares of Common Stock underlying the Warrants shall cease and terminate as to any particular number of the shares of Common Stock when such shares shall have
been effectively registered under the Securities Act and sold or otherwise disposed of in accordance with the intended method of disposition set forth in the Registration Statement covering such shares or at such time as an opinion of counsel or
other evidence reasonably satisfactory to the Company shall have been rendered to the effect that such conditions are not necessary in order to comply with the Securities Act. 
 
5. Conditions of each Investor’s Obligations at Closing. The obligations of each Investor under
subparagraph 1.1 of this Agreement are subject to the fulfillment on or before the Closing of each of the following conditions, the waiver of which shall not be effective against any Investor who does not consent in writing thereto: 
 
5.1 Representations and Warranties. The representations
and warranties of the Company contained in Section 2 shall be true and correct on and as of the Closing with the same effect as though such representations and warranties had been made on and as of the date of the Closing. 
 
5.2 Performance. The Company shall have performed and
complied with all agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with on or before the Closing. 
 
5.3 Compliance Certificate. The Chief Executive Officer of the Company shall have delivered to the
Investor at the Closing a certificate certifying that the conditions specified in Sections 5.1, 5.2 and 5.4 have been fulfilled. 
 
5.4 Qualifications. All authorizations, approvals or permits, if any, of any governmental authority or regulatory body of the
United States or of any state that are required in connection with the lawful issuance and sale of the Securities pursuant to this Agreement shall be duly obtained and effective as of the Closing. The Company shall have obtained all necessary

 

-17- 








blue sky permits and qualifications, or have the availability of exemptions therefrom, required by any
state for the offer and sale of the Shares and the Warrants. 
 
5.5 Opinion of Counsel. Investors shall have received the opinion of Pillsbury Winthrop LLP, counsel to the Company, in substantially the form of Exhibit C, attached hereto. 
 
5.6 Minimum Amount Sold. The Company shall have sold at
least such number of Shares hereunder at the Purchase Price to raise three million nine hundred twenty-five thousand dollars ($3,925,000). 
 
6. Conditions of the Company’s Obligations at Closing. The obligations of the Company to each Investor under this Agreement
are subject to the fulfillment (or waiver) on or before the Closing of each of the following conditions by the Investor: 
 
6.1 Representations and Warranties. The representations and warranties of such Investor contained in Section 3 shall be true on and
as of the Closing with the same effect as though such representations and warranties had been made on and as of the Closing. 
 
6.2 Qualifications. All authorizations, approvals or permits, if any, of any governmental authority or regulatory body of the
United States or of any state that are required in connection with the lawful issuance and sale of the Securities pursuant to this Agreement shall be duly obtained and effective as of the Closing. 
 
6.3 Minimum Amount Sold. The Company shall have sold at
least such number of Shares hereunder at the Purchase Price to raise three million nine hundred twenty-five thousand dollars ($3,925,000). 
 
7. Miscellaneous. 
 
7.1 Entire Agreement. This Agreement and the documents referred to herein and all Schedules and Exhibits thereto constitute the
entire agreement among the parties and no party shall be liable or bound to any other party in any manner by any warranties, representations or covenants except as specifically set forth herein or therein. 
 
7.2 Survival . The parties agree that, regardless of
any investigation made by the parties, the warranties, representations and covenants of the Company and the Investors contained in or made pursuant to this Agreement (including, without limitation, the provisions of Section 4) shall survive the
execution and delivery of this Agreement and the Closing. 
 
7.3 Successors and Assigns. Except as otherwise provided herein, the terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and assigns of the parties (including
permitted transferees of any Securities). Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations or liabilities
under or by reason of this Agreement, except as expressly provided in this Agreement. 
 

-18- 








 
7.4
Governing Law. This Agreement shall be governed by and construed under the laws of the State of California as applied to agreements among California residents entered into and to be performed entirely within California. 
 
7.5 Counterparts. This Agreement may be executed in two
or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 
 
7.6 Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be
considered in construing or interpreting this Agreement. 
 
7.7 Notices. Unless otherwise provided, any notice required or permitted under this Agreement shall be given in writing and shall be deemed given and effective when delivered personally, by telex or telecopier, or by overnight
express at the following addresses or to such other address as such party may designate by written notice to the other party in accordance with the provisions of this Section: 
 

	
	  If to the Company:
	   	  California Micro Devices Corporation
  430 N. McCarthy Blvd
  Milpitas, CA 95035-5112
  Attention: Robert V.
Dickinson
  Fax: (408) 934-2990

	
	  With a copy to:
	   	  Pillsbury Winthrop LLP
  2550 Hanover Street
  Palo Alto, CA 94304
  Attention: Stephen M.
Wurzburg
  Fax: (650) 233-4545

	
	  If to an Investor:
	   	  See the signature pages hereto



 
7.8 Expenses. Each party will bear its own expenses related to this Agreement and the transactions contemplated therein. 
 
7.9 Attorneys’ Fees. If any action at law or in equity is necessary to enforce or interpret the terms of this Agreement, the
prevailing party shall be entitled to reasonable attorneys’ fees, costs and disbursements in addition to any other relief to which such party may be entitled. 
 
7.10 Amendments and Waivers. Any term of this Agreement may be amended and the observance of any term
of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively), only with the written consent of the Company and the holders of more than a majority of the Shares sold hereunder and the
shares, if any, sold under similar agreements proximate in time to the Closing, provided that this Agreement and all agreements under which such other shares were sold under shall be amended identically or the observance of an identical term waived
identically, as the case may be. 
 
7.11
Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law, such provision shall be excluded from this Agreement and 
 

-19- 








the balance of this Agreement shall be interpreted as if such provision were so excluded and shall be
enforceable in accordance with its terms. 
 
7.12
Rights of the Investor. Each Investor shall have the absolute right to exercise or refrain from exercising any right or rights that such holder may have by reason of this Agreement or any Shares or Warrants, including without limitation the
right to consent to the waiver of any obligation of the Company under this Agreement and to enter into an agreement with the Company for the purpose of modifying this Agreement or any agreement effecting any such modification, and such Investor
shall not incur any liability to any other Investor with respect to exercising or refraining from exercising any such right or rights. 
 
7.13 Conflict of Interest Waiver. Each party to this Agreement acknowledges that Pillsbury Winthrop LLP (“PW”), counsel
for the Company, may have in the past and may continue in the future to perform legal services for certain of the Investors in matters unrelated to the transactions described in this Agreement, including the representation of such Investors in
formation of other companies, venture capital financings, and other matters. Accordingly, each party to this Agreement hereby (a) acknowledges that they have had an opportunity to ask for information relevant to this disclosure; (b) acknowledges
that PW represented the Company in the transaction contemplated by this Agreement and has not represented any individual Investor or any individual stockholder or employee of the Company in connection with such transaction, and (c) gives its
informed consent to PW’s representation of certain of the Investors in such unrelated matters and to PW’s representation of the Company in connection with this Agreement and the transactions contemplated hereby and in other matters.

 
7.14 Press Release/Form 8-K. The Company
agrees to issue a press release prior to the opening of the stock market on the first business day after the Closing and to file a Form 8-K with the SEC prior to the closing of the stock market on the first business day after the Closing, each
describing the critical features of the sale of the Shares and Warrants under this Agreement. 
 
[REMAINDER OF PAGE INTENTIONALLY BLANK] 
 

-20- 








 
IN WITNESS
WHEREOF, the parties have executed this Agreement as of the date first above written. 
 

	
	  CALIFORNIA MICRO DEVICES CORPORATION

	
	  By
	  	   


	  	  	  Robert V. Dickinson
  President and Chief Executive Officer



 
 
INVESTOR SIGNATURE PAGES TO FOLLOW 
 

-21- 








 
SIGNATURE
PAGE TO 
 
STOCK AND WARRANT PURCHASE
AGREEMENT 
 
DATED AS OF NOVEMBER 22, 2002

 
BY AND AMONG 
 
CALIFORNIA MICRO DEVICES CORPORATION 
 
AND EACH INVESTOR NAMED THEREIN 
 
The undersigned hereby executes and delivers the California
Micro Devices Corporation Stock and Warrant Purchase Agreement (the “Agreement”) to which this Signature Page is attached effective as of the date of the Agreement, which Agreement and Signature Page, together with all counterparts of such
signature pages of the other Investors named in such Agreement, shall constitute one and the same document in accordance with the terms of such Agreement. 
 
Number of Shares:________________________ 
 
_________________________________________________ 
Print Name of Investor 
 
By ______________________________________________ 
Signature 
 
Address: _________________________________________ 
 
                _________________________________________ 
 
                _________________________________________ 
 
Taxpayer Identification Number: _______________________ 
 
Investor is an “accredited investor” by reason of (check
one): 
 

	
	  Investor is an entity with gross assets in excess of $5,000,000.

	   	  _________

	
	  Investor is an individual with a net worth in excess of $1,000,000

	   	  _________

	
	  Investor is an individual and an Officer or Director of the Company

	   	  _________


 

-22- 








 
SCHEDULE A

 
INVESTORS 
 

	  Investor Name

	   	  Number of Shares
 
Purchased from Company

	   	  Investment
  In Dollars


	  T. Rowe Price (Oceanor & Co.)
	   	    150,000
	   	  $
	  510,000.00

	  Columbus Capital Partners, LP
	   	    300,000
	   	  $
	  1,020,000.00

	  Columbus Capital Offshore Fund Ltd
	   	      70,000
	   	  $
	  238,000.00

	  Lagunitas Partners LP
	   	    294,117
	   	  $
	  999,997.80

	  Gruber & McBaine International
	   	      73,529
	   	  $
	  249,998.60

	  Jon D. Gruber & Linda W. Gruber
	   	      73,529
	   	  $
	  249,998.60

	  The Tail Wind Fund Ltd
	   	    117,647
	   	  $
	  399,999.80

	  Proximity Partners, L.P.
	   	      30,882
	   	  $
	  104,998.80

	  Proximity Fund, L.P.
	   	      72,058
	   	  $
	  244,997.20

	  Capital Ventures International (Heights Capital)
	   	      73,529
	   	  $
	  249,998.60

	  Chad W. Keck
	   	      10,000
	   	  $
	  34,000.00

	  Edward C. Ross
	   	        5,000
	   	  $
	  17,000.00

	  Dan McCranie
	   	        7,500
	   	  $
	  25,500.00

	  Don Waite
	   	        7,500
	   	  $
	  25,500.00

	  Wade Meyercord
	   	        5,000
	   	  $
	  17,000.00

	  Stephen Wurzburg
	   	      12,000
	   	  $
	  40,800.00

	  Jeffrey Li
	   	        2,000
	   	  $
	  6,800.00

	  Anne Young and Kevin Low
	   	        4,000
	   	  $
	  13,600.00

	  TOTAL
	   	  1,308,291
	   	  $
	  4,448,189.40


 
Additionally, the
following investors have executed an identical Stock and Warrant Purchase Agreement, also dated November 22, 2002, with the only difference that the Closing under such Agreement is anticipated to occur on November 26, 2002: 
 

	  Investor Name

	   	  Number of Shares
 
Purchased from
  Company

	   	  Investment In
 
Dollars


	  Cranshire Capital, L.P.
	   	  100,000
	   	  $
	  340,000.00

	  Vertical Ventures Investments, LLC
	   	  110,294
	   	  $
	  374,999.60

	  TOTAL
	   	  210,294
	   	  $
	  714,999.60

	  TOTAL UNDER BOTH AGREEMENTS
	   	  1,518,585
	   	  $
	  5,163,189.00


 

SA-1 








SCHEDULE A 
 
INVESTORS 
 

	  Investor Name

	     	  Number of Shares Purchased from Company

	   	  Investment In
 
Dollars


	  Cranshire Capital, L.P.
	     	  100,000
	   	  $
	  340,000.00

	  Vertical Ventures Investments, LLC
	     	  110,294
	   	  $
	  374,999.60

	  TOTAL
	     	  210,294
	   	  $
	  714,999.60


 
Additionally, the
following investors have executed an identical Stock and Warrant Purchase Agreement, also dated November 22, 2002, with the only difference that the Closing under such Agreement occurred on November 25, 2002 
 

	  Investor Name

	   	  Number of Shares Purchased from Company

	   	  Investment In
 
Dollars


	  T. Rowe Price (Oceanor & Co.)
	   	  150,000
	   	  $
	  510,000.00

	  Columbus Capital Partners, LP
	   	  300,000
	   	  $
	  1,020,000.00

	  Columbus Capital Offshore Fund Ltd
	   	  70,000
	   	  $
	  238,000.00

	  Lagunitas Partners LP
	   	  294,117
	   	  $
	  999,997.80

	  Gruber & McBaine International
	   	  73,529
	   	  $
	  249,998.60

	  Jon D. Gruber & Linda W. Gruber
	   	  73,529
	   	  $
	  249,998.60

	  The Tail Wind Fund Ltd
	   	  117,647
	   	  $
	  399,999.80

	  Proximity Partners, L.P.
	   	  30,882
	   	  $
	  104,998.80

	  Proximity Fund, L.P.
	   	  72,058
	   	  $
	  244,997.20

	  Capital Ventures International (Heights Capital)
	   	  73,529
	   	  $
	  249,998.60

	  Chad W. Keck
	   	  10,000
	   	  $
	  34,000.00

	  Edward C. Ross
	   	  5,000
	   	  $
	  17,000.00

	  Dan McCranie
	   	  7,500
	   	  $
	  25,500.00

	  Don Waite
	   	  7,500
	   	  $
	  25,500.00

	  Wade Meyercord
	   	  5,000
	   	  $
	  17,000.00

	  Stephen Wurzburg
	   	  12,000
	   	  $
	  40,800.00

	  Jeffrey Li
	   	  2,000
	   	  $
	  6,800.00

	  Anne Young and Kevin Low
	   	  4,000
	   	  $
	  13,600.00

	  TOTAL
	   	  1,308,291
	   	  $
	  4,448,189.40

	  TOTAL UNDER BOTH AGREEMENTS
	   	  1,518,585
	   	  $
	  5,163,189.00


 

SA-1 








EXHIBIT A 
 
FORM OF WARRANT 
 


A-1 








THIS WARRANT AND THE SHARES ISSUABLE UPON ITS EXERCISE HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED. SUCH SECURITIES MAY NOT BE SOLD OR OTHERWISE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION THEREFROM UNDER SAID ACT. COPIES OF THE AGREEMENT COVERING THE PURCHASE OF THESE SECURITIES AND
RESTRICTING THEIR TRANSFER OR SALE MAY BE OBTAINED AT NO COST BY WRITTEN REQUEST MADE BY THE HOLDER OF RECORD HEREOF TO THE SECRETARY OF THE COMPANY AT ITS PRINCIPAL EXECUTIVE OFFICES. 
 
No. W-___ 
 
WARRANT TO PURCHASE COMMON STOCK 
OF 
CALIFORNIA MICRO DEVICES CORPORATION 
 
This certifies that, for value received as provided under a
Stock and Warrant Purchase Agreement dated November 22, 2002 (the “Purchase Agreement”), ______________________ (“Holder”) is entitled, subject to the terms and conditions set forth below, to purchase from California Micro
Devices Corporation, a California corporation (the “Company”), in whole or in part, such number of fully paid and nonassessable shares (the “Warrant Shares”) of no par value common stock of the Company (“Common Stock”)
equal to twenty-five percent (25%) of the number of shares of Common Stock purchased by Holder pursuant to the Purchase Agreement (the “Warrant Shares”) at the Exercise Price (as defined in Section 2). The number, character and Exercise
Price of such shares of Common Stock are subject to adjustment as provided below and all references to “Warrant Shares” and “Exercise Price” herein shall be deemed to include any such adjustment or series of adjustments. The term
“Warrant” as used herein shall mean this Warrant, and any warrants delivered in substitution or exchange therefor as provided herein. 
 
1. Term of Warrant. Subject to the terms and conditions set forth herein, this Warrant shall be exercisable, in whole or in part, during the term
commencing on the date hereof and ending at 5:00 p.m., Pacific standard time, on the third anniversary of issue, and shall be void thereafter (the “Exercise Period”). This Warrant shall expire prior to the end of Exercise Period if and
when it has been exercised in full. 
 
2. Exercise Price.
The Exercise Price shall be one hundred fifteen percent (115%) of the closing price of the Company’s common stock on the Nasdaq National Market on the trading day two days prior to the Closing under the Purchase Agreement. As so determined, the
Exercise Price is $4.36. 
 
3. Exercise of Warrant. This
Warrant may be exercised by the Holder only by the surrender of this Warrant to the Company, with the Notice of Exercise annexed hereto duly completed and executed on behalf of the Holder, at the office of the Company (or such other office or agency
of the Company as it may designate by notice in writing to the Holder appearing 
 

-1- 








on the books of the Company) during the Exercise Period, and the delivery of payment to the Company, for
the account of the Company, by cash, wire transfer of immediately available funds to a bank account specified by the Company, or by certified or bank cashier's check, of the Exercise Price for the number of Warrant Shares specified in the Exercise
Notice in lawful money of the United States of America. 
 
Notwithstanding any provisions herein to the contrary, if, Holder desires to exercise this Warrant on or after the date three (3) months following the Closing under the Purchase Agreement, and on such date of desired exercise (1) a
registration statement covering the Warrant Shares is not then effective with the SEC and (2) the fair market value of one share of the Common Stock (as determined below) is greater than the Exercise Price, then in lieu of exercising this Warrant
for cash, the Holder on such date may elect to receive shares of Common Stock equal to the value (as determined below) of this Warrant (or the portion thereof being exercised) by surrender of this Warrant at the principal office of the Company
together with the properly endorsed Notice of Exercise and notice of such election in which event the Company shall issue to the Holder a number of shares of Common Stock computed using the following formula: 
X = Y (A-B) 
         A 
Where  X  =  the number of shares of Common Stock to be issued to the Holder 
 

	  	 Y =	  	 the number of shares of Common Stock purchasable under the Warrant or, if only a portion of the Warrant is being exercised, the portion of the Warrant being
exercised (at the date of such calculation) 

 

	  	 A =	  	 the fair market value of one share of Common Stock (at the date of such calculation) 

 

	  	 B =	  	 the per share Exercise Price (as adjusted to the date of such calculation) 

 
For purposes of the above calculation, fair market value of one share of Common Stock shall be determined by the Company's
Board of Directors in good faith; provided, however, that in the event of that the Company’s Common Stock is listed or admitted to trading on a national or regional stock exchange or is included in any quotation service such as
the Nasdaq National Market, Nasdaq SmallCap Market or similar quotation service maintained by the National Quotation Bureau or any successor thereto, the fair market value shall be equal to the average of the closing price of the Company’s
Common Stock in the principal market where such Common Stock is traded on the five trading days immediately preceding the date on which the Warrant is exercised. 
 


-2- 








The Company agrees that such Warrant Shares shall be deemed to be issued to the Holder as
the record holder of such Warrant Shares as of the close of business on the date on which this Warrant shall have been surrendered and payment made for the Warrant Shares as aforesaid. A stock certificate or certificates for the Warrant Shares
specified in the Exercise Form shall be delivered to the Holder as promptly as practicable, and in any event within 10 days, thereafter. If this Warrant shall have been exercised only in part, the Company shall, at the time of delivery of the stock
certificate or certificates, deliver to the Holder a new Warrant evidencing the rights to purchase the remaining Warrant Shares, which new Warrant shall in all other respects be identical with this Warrant. No adjustments shall be made on Warrant
Shares issuable on the exercise of this Warrant for any cash dividends paid or payable to holders of record of Common Stock prior to the date as of which the Holder shall be deemed to be the record holder of such Warrant Shares. The Company shall
pay all expenses, taxes, and other charges payable in connection with the preparation, execution, and delivery of stock certificates pursuant to this Section 3. 
 
4. No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon
the exercise of this Warrant. In lieu of any fractional share to which the Holder would otherwise be entitled, the Company shall make a cash payment equal to the Exercise Price multiplied by such fraction. 
 
5. Replacement of Warrant. On receipt of evidence reasonably
satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form and substance to the Company or, in the
case of mutilation, on surrender and cancellation of this Warrant, the Company at its expense shall execute and deliver, in lieu of this Warrant, a new warrant of like tenor and amount. 
 
6. Rights of Shareholder. Subject to Sections 9 and 11 of this Warrant, the Holder shall not be entitled to vote or
receive dividends or be deemed the holder of Common Stock or any other securities of the Company that may at any time be issuable on the exercise hereof for any purpose, nor shall anything contained herein be construed to confer upon the Holder, as
such, any of the rights of a shareholder of the Company or any right to vote for the election of directors or upon any matter submitted to shareholders at any meeting thereof, or to give or withhold consent to any corporate action (whether upon any
recapitalization, issuance of stock, reclassification of stock, change of par value, or change of stock to no par value, consolidation, merger, conveyance of assets, or otherwise) or to receive notice of meetings, or to receive dividends or
subscription rights or otherwise until the Warrant shall have been exercised as provided herein. 
 
7. Transfer of Warrant. 
 
A. Warrant Register. The Company will maintain a register (the "Warrant Register") containing the names and addresses of the Holder or Holders. Any Holder of this Warrant or any portion thereof
may change his address as shown on the Warrant Register by written notice to the 
 

-3- 








Company requesting such change. Any notice or written communication required or permitted to be given to
the Holder may be delivered or given by mail to such Holder as shown on the Warrant Register and at the address shown on the Warrant Register. Until this Warrant is transferred on the Warrant Register of the Company, the Company may treat the Holder
as shown on the Warrant Register as the absolute owner of this Warrant for all purposes, notwithstanding any notice to the contrary. 
 
B. Warrant Agent. The Company may, by written notice to the Holder, appoint an agent for the purpose of maintaining the Warrant
Register referred to in Section 7(A) above, issuing the Warrant Shares or other securities then issuable upon the exercise of this Warrant, exchanging this Warrant, replacing this Warrant, or any or all of the foregoing. Thereafter, any such
registration, issuance, exchange, or replacement, as the case may be, shall be made at the office of such agent. 
 
C. Transferability and Nonnegotiability of Warrant. This Warrant may be transferred to “affiliates” of the Holder, as
defined in Rule 405, as promulgated by the Securities and Exchange Commission (the “SEC”) and, with the prior written consent of the Company, to other persons, provided that such transferee agrees to be bound by the other restrictions on
transfer applicable to the Warrant Shares. Notwithstanding the foregoing, this Warrant may not be transferred or assigned in whole or in part without compliance with all applicable federal and state securities laws by the transferor and the
transferee (including the delivery of investment representation letters and legal opinions reasonably satisfactory to the Company, if such are requested by the Company). However, no investment representation letter or opinion of counsel shall be
required for any transfer of this Warrant (or any portion thereof) or any shares of Common Stock issued upon exercise hereof in compliance with Rule 144(k) and no opinion of counsel shall be required for any transfer of this Warrant (or any portion
thereof) in compliance with Rule 144A; provided that in each of the foregoing cases the transferee agrees in writing to be subject to the terms of this Section 7(C). Subject to the provisions of this Warrant with respect to compliance with the
Securities Act of 1933, as amended (the "Act"), title to this Warrant may be transferred by endorsement (by the Holder executing the Assign­ment Form annexed hereto) and delivery in the same manner as a negotiable instrument transferable by
endorsement and delivery. 
 
D. Exchange of
Warrant Upon a Transfer. On surrender of this Warrant for transfer, properly endorsed on the Assignment Form and subject to the provisions of this Warrant with respect to compliance with the Act and with the limitations on assign­ments and
transfers and contained in this Section 7, the Company at its expense shall issue to or on the order of the Holder a new warrant or warrants of like tenor, in the name of the Holder or as the Holder (on payment by the Holder of any applicable
transfer taxes) may direct, for the number of shares issuable upon exercise hereof. 
 
E. Compliance with Securities Laws. 
 
i. The Holder of this Warrant, by acceptance hereof, represents that it is an “accredited investor” within the
meaning of Rule 501 of Regulation D of the Securities Act of 1933, as amended, as presently in effect. 
 

-4- 








ii. The Holder acknowledges that this Warrant is being, and the Warrant
Shares would be, acquired solely for the Holder's own account and not as a nominee for any other party, and for investment, and that the Holder will not offer, sell or otherwise dispose of this Warrant or any Warrant Shares except under
circumstances that will not result in a violation of the Act or any applicable state securities laws. Upon exercise of this Warrant, the Holder shall, if requested by the Company, confirm in writing, in a form satisfactory to the Company, that the
Warrant Shares are being acquired solely for the Holder's own account and not as a nominee for any other party, for investment, and not with a view toward distribution or resale. 
 
iii. This Warrant and Warrant Shares shall be stamped or imprinted with a legend in
substantially the following form (in addition to any legend required by state securities laws): 
 
THIS WARRANT AND THE SHARES ISSUABLE UPON ITS EXERCISE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. SUCH SECURITIES MAY NOT BE SOLD OR OTHERWISE TRANSFERRED IN THE ABSENCE OF
SUCH REGISTRATION OR AN EXEMPTION THEREFROM UNDER SAID ACT. COPIES OF THE AGREEMENT COVERING THE PURCHASE OF THESE SECURITIES AND RESTRICTING THEIR TRANSFER OR SALE MAY BE OBTAINED AT NO COST BY WRITTEN REQUEST MADE BY THE HOLDER OF RECORD HEREOF TO
THE SECRETARY OF THE COMPANY AT ITS PRINCIPAL EXECUTIVE OFFICES. 
 
The Company agrees to remove promptly, upon the request of the holder of this Warrant or the Warrant Shares, the legend set forth in Section 7(E)(iii) above from the documents/certificates for such
securities upon full compliance with this Agreement and either Rule 144(k) or after a sale in the public market in compliance with Rule 144. 
 
8. Reservation of Stock. The Company covenants that during the term this Warrant is exercisable, the Company will reserve from its authorized and
unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares and, from time to time, will take all steps necessary to amend its Articles of Incorporation to provide sufficient reserves of shares of Common
Stock for the issuance of the Warrant Shares. The Company further covenants that all Warrant Shares, upon exercise of this Warrant and payment of the Exercise Price, all as set forth herein, will be free from all taxes, liens and charges in respect
of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously or otherwise specified herein). 
 
9. Notices. 
 
A. In case: 
 
i. the Company shall take a record of the holders of its Common Stock for 
 

-5- 








the purpose of entitling them to receive any dividend or other distribution, or any right
to subscribe for or purchase any shares of stock of any class or any other securities, or to receive any other right; 
 
ii. of any capital reorganization of the Company, any reclassification of the capital stock of the Company, any
consolidation or merger of the Company with or into another corporation, or any conveyance of all or substantially all of the assets of the Company to another corporation; or 
 
iii. of any voluntary dissolution, liquidation or winding-up of the Company; 
 
then, and in each such case, the Company will mail or cause to
be mailed to the Holder or Holders a notice specifying, as the case may be, (A) the date on which a record is to be taken for the purpose of such dividend, distribution or right, and stating the amount and character of such dividend, distribution or
right, or (B) the date on which such reorganization, reclassifi­cation, consolidation, merger, conveyance, dissolution, liquida­tion, or winding-up is to take place, and the time, if any is to be fixed, as of which the holders of record of
Common Stock shall be entitled to exchange their shares of Common Stock for securities or other property deliverable upon such reorganization, reclassification, consolidation, merger, conveyance, dissolu­tion, liquidation or winding-up. Such
notice shall be mailed no later than the time similar notice is mailed to the holders of Company Common Stock. 
 
B. All such notices, advices and communications as required by the terms of this Warrant shall be made and be deemed to have been received
(i) in the case of personal delivery, on the date of such delivery, (ii) in the case of next day courier service such as Federal Express, one business day after it is delivered to the courier service for US addresses and two business days for
foreign addresses, and (iii) in the case of mailing by certified mail, on the third business day following the date of such mailing if sent to a U.S. address and on the tenth (10th) business day following the date of such mailing if sent to an
address outside the U.S. 
 
10. Amendments. This Warrant and
any term hereof may be changed, waived, discharged or terminated only by an instrument in writing signed by the Company or the Holder of the Warrant against which enforcement of such change, waiver, discharge or termination is sought. An amendment
of rights, preferences, or privileges of the Common Stock, including a change in the par value of the Common Stock; an event described in Section 9A or 11A of this Warrant; or any other like action shall not be treated as an amendment of this
Warrant. 
 
11. Adjustments. The Exercise Price and the
number of shares purchasable hereunder are subject to adjustment from time to time as follows: 
 
A. Reclassification, etc. If the Company, at any time while this Warrant, or any portion thereof, remains outstanding and unexpired, by reorganization or reclassification of securities or
otherwise, shall change any of the securities as to which purchase rights under this Warrant exist into the same or a different number of securities of any other class or classes, this Warrant shall thereafter represent the right to acquire such
number and kind of securities as would have been issuable as the result of such change with respect to the securities that were 
 

-6- 








subject to the purchase rights under this Warrant immediately prior to such reorganization or
reclassification or other change and the Exercise Price therefor shall be appropriately adjusted, all subject to further adjustment as provided in this Section 11. 
 
B. Split, Subdivision or Combination of Shares. If the Company at any time while this Warrant, or any
portion thereof, remains outstanding and unexpired shall split, subdivide or combine the securities as to which purchase rights under this Warrant exist, into a different number of securities of the same class, then (i) in the case of a split or
subdivision, the Exercise Price for such securities shall be proportionately decreased and the securities issuable upon exercise of this Warrant shall be proportionately increased, and (ii) in the case of a combination, the Exercise Price for such
securities shall be proportionately increased and the securities issuable upon exercise of this Warrant shall be proportionately decreased. 
 
C. Adjustments for Distributions in Stock or Other Securities or Property. If while this Warrant, or any portion hereof, remains
outstanding and unexpired the holders of the securities as to which purchase rights under this Warrant exist at the time shall have received, or, on or after the record date fixed for the determination of eligible Shareholders, shall have become
entitled to receive, without payment therefor, other or additional stock or other securities or property (other than cash) of the Company by way of dividend or otherwise, then and in each case, this Warrant shall represent the right to acquire, in
addition to the number of shares of the security receivable upon exercise of this Warrant, and without payment of any additional consideration therefor, the amount of such other or additional stock or other securities or property (other than cash)
of the Company that such holder would hold on the date of such exercise had it been the holder of record of the security receivable upon exercise of this Warrant on the date hereof and had thereafter, during the period from the date hereof to and
including the date of such exercise, retained such shares and/or all other additional stock available by it as aforesaid during such period, giving effect to all adjustments called for during such period by the provisions of this Section 11.

 
D. Mergers, Consolidation, or Asset Sale.
If any merger or consolidation of the Company with or into another corporation, or the sale of substantially all of its assets to another corporation, shall be effected in such a way that holders of shares of Common Stock shall be entitled to
receive common stock, other securities, or assets with respect to or in exchange for shares of Common Stock, then, as a condition to such merger, consolidation, or asset sale, adequate provision shall be made whereby the Holder of Warrants shall
thereafter have the right to receive such shares of common stock, other securities, or assets upon the exercise of the Warrant as though the Holder had exercised the Warrant in full immediately prior to such merger, consolidation, or asset sale and
received Shares which were thereafter effected by the merger, consolidation, or asset sale and the resulting shares of common stock, other securities, or assets were thereafter held and effected by any subsequent events. Notwithstanding the
foregoing, if only cash, assets, and/or promissory notes not convertible into equity are issued in such merger, consolidation, or asset sale, then the Company may cause the Warrants to terminate upon the consummation of such merger, consolidation,
or asset sale, provided that the Company has provided the Holder with at least fifteen (15) business days notice of such merger, consolidation, or asset sale. 
 

-7- 








 
E.
Certificate as to Adjustments. Upon the occurrence of each adjustment or readjustment pursuant to this Section 11, the Company at its expense shall promptly compute such adjustment or readjustment in accordance with the terms hereof and
furnish to each Holder of this Warrant a certificate setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based. The Company shall, upon the written request, at any time, of any
such Holder, furnish or cause to be furnished to such Holder a like certificate setting forth: (i) such adjustments and readjustments; (ii) the Exercise Price at the time in effect; and (iii) the number of shares and the amount, if any, of other
property that at the time would be received upon the exercise of the Warrant. 
 
F. No Impairment. The Company will not, by any voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder by the Company,
but will at all times in good faith assist in the carrying out of all the provisions of this Warrant and in the taking of all such action as may be necessary or appropriate in order to protect the rights of the Holder against impairment. An event
described above in this subsections A, B, C, and D of this Section 11 for which appropriate adjustment is made or an event described in Section 9A of which the Holder is given timely notice pursuant to Section 9, shall not be deemed under any
circumstance to be an impairment of this Warrant. 
 
12.
Miscellaneous. 
 
A. This Warrant shall be
governed by the internal laws of the State of California as applied to agreements entered into in the State of California by and among residents of the State of California, without reference to the conflicts of laws provisions therein. 
 
B. In the event of a dispute with regard to the interpretation
of this Warrant, the prevailing party may collect the cost of attorney's fees, litigation expenses or such other expenses as may be incurred in the enforcement of the prevailing party's rights hereunder. 
 
C. This Warrant shall be exercisable as provided for herein,
except that in the event that the expiration date of this Warrant shall fall on a Saturday, Sunday and or United States federally recognized Holiday, the expiration date for this Warrant shall be extended to 5:00 p.m. Pacific standard time on the
business day following such Saturday, Sunday or recognized Holiday. 
 
D. This Warrant and any document or agreements executed by the parties pursuant to this Warrant constitute the full and complete understanding of the parties hereto with respect to the subject matter hereof and supersede all
previous agreements or understandings, written or oral, between the parties with respect thereto. 
 
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 
 

-8- 








In witness whereof, California Micro Devices Corporation has caused this Warrant to be
executed by its officer thereunto duly authorized. 
 
Dated: November __, 2002 
 

	  Company:
   

	  California Micro Devices Corporation

	
	  By
  

	  	   

  Robert V. Dickinson, President



 

-9- 








 
NOTICE OF
EXERCISE 
 
To: California Micro Devices
Corporation 
 
The undersigned hereby elects to purchase __________
shares of Common Stock of California Micro Devices Corporation pursuant to the terms of the attached Warrant, and tenders herewith payment of the purchase price for such shares in full. 
 
In exercising this Warrant, the undersigned hereby confirms and acknowledges that the shares of Common Stock to be issued
upon conversion thereof are being acquired solely for the account of the undersigned and not as a nominee for any other party, or for investment, and that the undersigned will not offer, sell or otherwise dispose of any such shares of Common Stock
except under circumstances that will not result in a violation of the Securities Act of 1933, as amended, or any applicable state securities laws. 
 
Please issue a certificate or certificates representing said shares of Common Stock in the name of the undersigned or in such other name as is specified
below: 
 
___________________________________________ 
(Name) 
 
___________________________________________ 
(Name) 
 
Please issue a new Warrant for the unexercised portion of the attached Warrant in the name of the undersigned or in such other name as is specified below:

 
___________________________________________

(Name) 
 

	  __________________
	  	  ________________________________________

	  (Date)
	  	  (Signature)


 

-10- 








ASSIGNMENT FORM 
 
FOR VALUE RECEIVED, the undersigned registered owner of this Warrant hereby sells, assigns and transfers unto
the Assignee named below all of the rights of the under­signed under the within Warrant, with respect to the number of shares of Common Stock set forth below: 
 

	  Name of Assignee

	   	  Address

	   	  Number of Shares



 
and does
hereby irrevocably constitute and appoint Attorney ______________________ to make such transfer on the books of California Micro Devices Corporation, maintained for the purpose, with full power of substitution in the premises. 
 
If the Assignee is an “affiliate”, as defined in
Rule 405, promulgated by the SEC, please explain the basis for such determination: ________________________________________________________________________________________. 
 
The undersigned also represents that, by assignment hereof, the Assignee acknowledges that this Warrant and
the shares of stock to be issued upon exercise hereof are being acquired for investment and that the Assignee will not offer, sell or otherwise dispose of this Warrant or any shares of stock to be issued upon exercise hereof except under
circumstances which will not result in a violation of the Securities Act of 1933, as amended, or any applicable state securities laws. Further, the Assignee has acknowledged that upon exercise of this Warrant, the Assignee shall, if requested by the
Company, confirm in writing, in a form satisfactory to the Company, that the shares of stock so purchased are being acquired for investment and not with a view toward distribution or resale. 
 
Dated: _______________. 
 
_____________________________________

                            Signature of Holder 
 

-11- 








 
EXHIBIT B

 
CALIFORNIA MICRO DEVICES CORPORATION

CERTIFICATE OF SUBSEQUENT SALE 
 

	  	 RE:	  	 Sale of Shares of Common Stock of California Micro Devices Corporation (the “Company”) pursuant to the Company’s Prospectus dated
            , 2002 (the “Prospectus”) 

 
Dear Sir/Madam: 
 
The undersigned hereby certifies, in connection with the sale of shares of Common Stock of the Company included in the table of Selling
Stockholders in the Prospectus, that the undersigned has sold the Shares pursuant to the Prospectus and in a manner described under the caption “Plan of Distribution” in the Prospectus and that such sale complies with all applicable
securities laws, including, without limitation, the Prospectus delivery requirements of the Securities Act of 1933, as amended. 
 
Selling Stockholder (the beneficial owner):
                                       
                                        
                                        
            
 
Record Holder (e.g., if held in name of nominee):
                                       
                                        
                                       
 
Restricted Stock Certificate
No.(s):                                       
                                        
                                        
                            
 
Number of Shares
Sold:                                       
                                        
                                        
                                        
         
 
Date of Sale:                                
                                        
                                        
                                        
                                     
 
In the event that you receive a stock certificate(s)
representing more shares of Common Stock than have been sold by the undersigned, then you should return to the undersigned a newly issued certificate for such excess shares in the name of the Record Holder and BEARING A RESTRICTIVE LEGEND. Further,
you should place a stop transfer on your records with regard to such certificate. 
 

	  Very truly yours,

	
	  By
	  	   


	
	  Print Name
	  	   


	
	  Title
	  	   




 
 
Dated:_____________________  
 

	 cc:	  	 Pillsbury Winthrop LLP 

2550 Hanover Street 
Palo Alto, California 94304 
Attn: Stephen M. Wurzburg 
 
 

B-1 








 
EXHIBIT C

 
OPINIONS OF COMPANY COUNSEL

 
 

C-1 








2550 HANOVER STREET PALO ALTO,
CA    94304-1115    650.233.4500    F:650.233.4545 
 
November 25, 2002 
 
To the Investors Named 
on Schedule A to the 
Stock and Warrant Purchase Agreement

Referred to Below: 
 

	  	 Re:	  	 California Micro Devices Stock and Warrant Purchase Agreement 

 
Ladies and Gentlemen: 
 
We have acted as counsel for California Micro Devices Corporation, a
California corporation (the “Company”), in connection with the Stock and Warrant Purchase Agreement dated as of November 22, 2002 (the “Agreement”), by and between the Company and each of you. This letter is provided to you in
satisfaction of the requirements set forth in Section 5.5 of the Agreement. The Agreement provides, among other things, for the sale and purchase of shares (the “Shares”) of the Company’s no par value Common Stock (the “Common
Stock”) and warrants (the “Warrants”) to purchase shares of Common Stock (the “Warrant Shares”). Terms not otherwise defined herein have the meanings given them in the Agreement. 
 
In connection with the foregoing, we have examined the Agreement and its
exhibits, including the form of Warrant, the Private Placement Memorandum dated October 14, 2002, records of proceedings of the directors and shareholders of the Company, the Amended and Restated Articles of Incorporation, the Bylaws of the Company,
certificates of officers of the Company and public officials, and such other documentation as we have deemed necessary or advisable in order to render the opinions expressed herein. 
 
Based upon the foregoing and subject to the assumptions, qualifications, limitations and exceptions set forth below, it is
our opinion that: 
 
1. The Company has been duly
incorporated and is a validly existing corporation in good standing under the laws of the State of California and has the requisite corporate power to own its property and assets and to conduct its business as it is currently being conducted.








 
To the Investors Named on Schedule A 
of the Stock and Warrant Purchase Agreement

November 25, 2002 
Page 2 
 
2. The Company has all requisite corporate power and authority to execute and deliver the Agreement and to perform its obligations under
the terms of such Agreement. The Agreement has been duly and validly authorized, executed and delivered by the Company and constitute a valid and binding agreement of the Company, enforceable against the Company in accordance with its respective
terms, except insofar as indemnification and contribution provisions contained therein may be limited by applicable law or the application of principles of public policy. 
 
3. The execution and delivery by the Company of the Agreement and the performance by the Company of its
obligations thereunder and the issuance of the Shares and Warrants pursuant to the Agreement do not violate the Company’s Amended and Restated Articles of Incorporation or Bylaws, and do not (i) violate or contravene any governmental statute,
rule or regulation applicable to the Company that in our experience is generally applicable to transactions of the type contemplated by the Agreement (without our having made any investigation concerning the applicability of any other statue, rule
or regulation) or (ii) violate or contravene any order, writ, judgment, injunction, decree, determination or award known to us that has been entered against the Company. 
 
4. We are not aware of any action, suit, proceeding or investigation pending against the Company before any
court or administrative agency, or that the Company has received any written threat thereof, that questions the validity of the Agreement. 
 
5. No approval, authorization or other action by any federal or state governmental authority or filing (other than filings solely for
information purposes or to obtain action that is not the subject of governmental discretion) with any such authority that has not been obtained or accomplished is required in connection with the execution, delivery and performance by the Company of
the Agreement.  
 
6. The Shares and
Warrants have been duly authorized and, the Shares and Warrant Shares, upon issuance and delivery against payment therefor in accordance with the terms of the Agreement, will be validly issued, fully paid and nonassessable. 
 
7. Based in part upon your representations in Section 3 of the
Agreement, the offer and sale of the Shares and Warrants pursuant to the terms of the Agreement are exempt from the registration requirements of Section 5 of the Securities Act of 1933, as amended, and the offer and sale of the Shares, Warrants, and
Warrant Shares pursuant to 







To the Investors Named on Schedule A 
of the Stock and Warrant Purchase Agreement 
November 25, 2002 
Page 3 
 
the terms
of the Agreement are exempt from the qualification requirements of the California Corporate Securities Law of 1968, as amended. 
 
The foregoing opinion is subject to such matters as are set forth in the Agreement and the following assumptions, qualifications, limitations and
exceptions: 
 
(a) We have assumed
the genuineness of all signatures, the authenticity and completeness of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as photostatic or telecopied originals, the legal capacity of
all natural persons, and as to documents executed by entities other than the Company, that each such entity has complied with any applicable requirement to file tax returns and pay taxes under California Franchise Tax law and had the power to enter
into and perform its obligations under such documents, and that such documents have been duly authorized, executed and delivered by, and are binding upon and enforceable against such entities. We have also assumed that the representations and
warranties made by the Company in the Agreement are true and correct as to matters of fact and that the representations and warranties made by each of you in the Agreement are true and correct. 
 
(b) This opinion is limited in all respects
to matters governed by the laws of the State of California and the federal laws of the United States, and we express no opinion concerning the laws or regulations of any other jurisdiction or jurisdictions. We express no opinion as to federal or
state antifraud or antitrust laws or regulations or, except as expressly provided in paragraph 7 above, to the securities or blue sky law of any jurisdiction. We express no opinion in clause (i) of Paragraph 3 as to ordinances and regulations of
counties and political subdivisions thereof. 
 
(c) We assume that you know of no agreements, understandings or negotiations between the parties not set forth in the Agreement that would modify the terms or rights and obligations of the parties thereunder. 
 
(d) Our opinion in paragraph 2 above is
subject to and limited by (i) the effect of applicable bankruptcy, insolvency, reorganization, receivership, conservatorship, arrangement, moratorium or other laws affecting or relating to the rights of creditors generally, (ii) the rules governing
the availability of specific performance, injunctive relief or other equitable remedies and general principles 







To the Investors Named on Schedule A 
of the Stock and Warrant Purchase Agreement 
November 25, 2002 
Page 4 
 
of equity, whether considered in a proceeding in equity or at law, (iii) the effect of applicable court decisions, invoking statutes or principles of equity, which have held that certain covenants and provisions of agreements are
unenforceable where the breach of such covenants or provisions imposes restrictions or burdens upon a party thereto, and it cannot be demonstrated that the enforcement of such restrictions or burdens is reasonably necessary for the protection of the
other party, or the enforcement of such covenants or provisions under the circumstances would violate the covenant of good faith and fair dealing implied under applicable law, and (iv) the effect of California Civil Code Section 1698 and of statutes
and rules of law that cannot be waived prospectively by an obligor. 
 
(e) Whenever a statement herein is qualified by “to our knowledge,” “known to us,” “we are not aware,” or similar phrase, it indicates that in the course of our
representation of the Company no information that would give us current actual knowledge of the inaccuracy of such statement has come to the attention of the attorneys in this firm who have rendered legal services in connection with this
transaction. We have not made any independent investigation to determine the accuracy of such statement, except as expressly described herein. No inference as to our knowledge of any matters bearing on the accuracy of such statement should be drawn
from the fact of our representation of the Company in other matters in which such attorneys are not involved. 
 
This opinion is rendered solely for your information in connection with the transaction described above and may not be delivered to or relied upon by any other person for any purpose without our prior
written consent. 
 
Very truly
yours, 







 
EXHIBIT D

 
SCHEDULE OF EXCEPTIONS 
 
Section 2.15 Employee Benefit Plans

 
The Company maintains a deferred compensation
plan for its officers whereby such officers may defer a portion of their salary and such salary deferrals, plus a matching contribution by the Company, are placed in a Rabbi Trust. 
 

D-1